Top Growth Stocks Revenue

Nuclear Power, Made in USA: Centrus Becomes a Strategic Beneficiary

Trump's new nuclear initiative gives Centrus a boost: the stock jumps by nearly 20% Impressive...

Hims & Hers: Sharp Correction After the end of the FDA Exception and Cigna Offensive

Regulatory changes and new pricing strategies are slowing down the rise of the telemedicine stock...

Coeur Mining: When Patience Finally Pays off

Strong first quarter: Revenue nearly doubled, operating margin also – Coeur Mining delivers operationally,...

“Quantum is Like AI in 2015” – Google Anticipates a Breakthrough, D-Wave Already Delivers

Google CEO Sundar Pichai sees the breakthrough of quantum computing by 2030 – D-Wave is one of the...

Roblox Impresses With Strong Figures – Platform Economy on the Rise

Roblox significantly exceeds analysts' expectations in Q1 2025 Platform instead of game: Roblox...

Hims & Hers Health: an Important day – Refinancing, Political Tailwind, and Short Dynamics

Billion-dollar financing ignites growth surge: Hims & Hers secures $1 billion through a convertible...

Hims & Hers Health: Partnership With Novo Nordisk Causes Sensation

Hims & Hers surprises with strategic alliance instead of litigation: Novo Nordisk opts against...

Guardant Health: The Silent Revolution in Cancer Diagnostics

Blood-based cancer diagnostics on the way to becoming the new standard – with billion-dollar potential....

Duolingo's Next Move

The learning platform is entering a new growth area in the digital education market with chess –...

StoneX: The Winner That's not in the Headlines

StoneX is showing high stability during turbulent times Strong earnings, low valuation, growing...

Alignment Healthcare: Innovation in U.S. Healthcare for Seniors

Holistic Care for Seniors: Alignment combines data-driven prevention with personalized care as part...

Robinhood is Riding the Trump Wave: Record Trading After Political Turnaround

Robinhood benefits massively from historically high trading volumes following Trump's tariff pause...

Rhythm Achieves Breakthrough in Rare Obesity – Study Success Fuels Stock Expectations

• Success with IMCIVREE®:  Rhythm achieves breakthrough in previously untreatable form of obesity...

Cloudflare Acquires Outerbase – AI Applications Made Easy

• Data for everyone: Cloudflare acquires Outerbase and enables the development of AI-driven apps...

Hims & Hers: CEO Dudum Aims to Gain Market Share During the Crisis

Despite FDA setback and stock plunge, Hims is focusing on expansion rather than retreat – with a...

Education Without a Federal Department? Duolingo Could Profit From Trump's Plans!

• Trump's call for the abolition of the Department of Education brings private educational providers...

Cloudflare: From CDN Provider to AI Infrastructure Player – Analysts see Potential for Doubling Stock Price

Cloudflare grows from a CDN provider to an AI infrastructure pioneer – fueled by AIaaS and network...

Catalyst Pharmaceuticals: High-Growth Specialist for Rare Diseases

  Successful with Orphan Drugs: Catalyst excels with high-margin niche products like FIRDAPSE...

Liberty Media Picks up the pace in Terms of Formula 1

Why Netflix, LVMH and Brad Pitt are part of the new F1 strategy – and what investors can gain from...

Robinhood Launches an Event Trading Platform – the Stock Rises by 7%

Robinhood expands its trading offerings, allowing investors to trade event contracts, including bets...

Duolingo: AI as a Growth Driver – is There a Second Chance for Investors now?

• Data advantage as a moat:  With over one billion language exercises daily , Duolingo perfects...

Robinhood Pays a $29.75 Million Fine – the Stock Plummets, but ARK Capitalizes on the low

Robinhood under pressure: The online broker pays a fine of $29.75 million due to compliance violations,...

Arcutis Biotherapeutics: Cortisone-Free Ointment ZORYVE as a new Alternative for Eczema

Rapid Revenue Increase: ZORYVE is growing with +471% revenue in 2024 and establishing itself as an alternative...